The Performances of Three Commercially Available Assays for the Detection of SARS-CoV-2 Antibodies at Different Time Points Following SARS-CoV-2 Infection

The Performances of Three Commercially Available Assays for the Detection of SARS-CoV-2 Antibodies at Different Time Points Following SARS-CoV-2 Infection

The aim of this study was to evaluate the performances of three commercially available antibody assays for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies at different time points following SARS-CoV-2 infection. Sera from 536 cases, including 207 SARS-CoV-2 P...

Full description

Bibliographic Details
Main Authors: Heidi Syre, Marius Eduardo Brå Obreque, Ingvild Dalen, Åse Garløv Riis, Åse Berg, Iren Høyland Löhr, Jon Sundal, Lars Kåre Kleppe, May Sissel Vadla, Ole Bernt Lenning, Jan Stefan Olofsson, Kristin Greve-Isdahl Mohn, Camilla Tøndel, Bjørn Blomberg, Mai Chi Trieu, Nina Langeland, Rebecca Jane Cox
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Viruses
Subjects:
SARS-CoV-2
antibody assay
spike
receptor binding domain
nucleocapsid
Online Access:https://www.mdpi.com/1999-4915/14/10/2196

Similar Items

Similar Items